Because of their obvious efficiencies and superior efficacy, the biopharmaceutical industry will continue to focus on targeted medicines in cancer and other therapeutic areas. Learn about five steps that will help companies better manage the complexity and risk of working in this space.
Other content in this Stream
Learn about five economical and efficient ways to make early phase trials both patient-centric and more effective.
Highest level of accreditation from the UK Medicines and Healthcare Regulatory Agency for Phase I clinical study units to carry out studies with compounds at all levels of risk.
In-house scientific and medical expertise, combined with the latest in clinical and research technology.
One of the world’s largest Japanese Phase I units. Pioneered the conduct of Asian (Japanese, Chinese and Korean) ethnobridging studies outside of Asia in 2001.
Our team of full-time physicians, nurses, and qualified research staff has extensive experience conducting healthy volunteer and patient studies with challenging designs and timelines.
Take a tour
Improve clinical trial outcomes and prevent costly delays.